Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Herrmann

Showing results (51-60 of 229) with videos related to

Pageof 23
Sort By:
Oncology|May 24, 2008
Short time to progression under first-line chemotherapy is a negative prognostic factor for time to progression and residual survival under second-line chemotherapy in advanced pancreatic cancerChristina Herrmann, Ulrich Abel, Wolfgang Stremmel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 17, 2006
A process for making cutaneous radiation applicators based on digital dataSteffen Schreiber, Bernd Reitemeier, Thomas Herrmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 4, 2004
[Early loss of teeth after treatment for childhood leukemia]Thomas Herrmann, Wolfgang Dörr, Susanne Koy, et al.
Plos One|December 14, 2011
Characterization of a new mouse model for peripheral T cell lymphoma in humansNiklas Beyersdorf, Sandra Werner, Nelli Wolf, et al.
Journal of Endourology|December 24, 2011
Comparison of 120-200 W 2 μm thulium:yttrium-aluminum-garnet vapoenucleation of the prostateChristopher Netsch, Thorsten Bach, Laura Pohlmann, et al.
The Journal of Chemical Physics|June 22, 2007
Ab initio design of picosecond infrared laser pulses for controlling vibrational-rotational excitation of CO moleculesThomas Herrmann, Qinghua Ren, Gabriel G Balint-Kurti, et al.
World Journal of Urology|May 2, 2020
Intravesical therapy for bladder cancer in the pandemic of Covid-19Jeremy Y C Teoh, Morgan Roupret, Shahrokh F Shariat, et al.
Immunobiology|February 1, 2017
Robust 8-color flow cytometry panel reveals enhanced effector function of NKG2C<sup>+</sup> CD57<sup>+</sup> FcεRγ<sup>-</sup> NK cells in CMV seropositive human blood donorsThomas Nerreter, Stephan Zeiß, Thomas Herrmann, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|July 5, 2007
[Setting up an interdisciplinary cancer center between the poles of internal and external interests]Michael Baumann, Gerhard Ehninger, Thomas Herrmann, et al.
World Journal of Urology|May 19, 2019
Outcomes of ureteroscopy for stone disease in anomalous kidneys: a systematic reviewLisa Lavan, Thomas Herrmann, Christopher Netsch, et al.
Pageof 23

Showing results (51-60 of 229) with videos related to

Sort By:
Pageof 23
Oncology|May 24, 2008
Short time to progression under first-line chemotherapy is a negative prognostic factor for time to progression and residual survival under second-line chemotherapy in advanced pancreatic cancerChristina Herrmann, Ulrich Abel, Wolfgang Stremmel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 17, 2006
A process for making cutaneous radiation applicators based on digital dataSteffen Schreiber, Bernd Reitemeier, Thomas Herrmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 4, 2004
[Early loss of teeth after treatment for childhood leukemia]Thomas Herrmann, Wolfgang Dörr, Susanne Koy, et al.
Plos One|December 14, 2011
Characterization of a new mouse model for peripheral T cell lymphoma in humansNiklas Beyersdorf, Sandra Werner, Nelli Wolf, et al.
Journal of Endourology|December 24, 2011
Comparison of 120-200 W 2 μm thulium:yttrium-aluminum-garnet vapoenucleation of the prostateChristopher Netsch, Thorsten Bach, Laura Pohlmann, et al.
The Journal of Chemical Physics|June 22, 2007
Ab initio design of picosecond infrared laser pulses for controlling vibrational-rotational excitation of CO moleculesThomas Herrmann, Qinghua Ren, Gabriel G Balint-Kurti, et al.
World Journal of Urology|May 2, 2020
Intravesical therapy for bladder cancer in the pandemic of Covid-19Jeremy Y C Teoh, Morgan Roupret, Shahrokh F Shariat, et al.
Immunobiology|February 1, 2017
Robust 8-color flow cytometry panel reveals enhanced effector function of NKG2C<sup>+</sup> CD57<sup>+</sup> FcεRγ<sup>-</sup> NK cells in CMV seropositive human blood donorsThomas Nerreter, Stephan Zeiß, Thomas Herrmann, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|July 5, 2007
[Setting up an interdisciplinary cancer center between the poles of internal and external interests]Michael Baumann, Gerhard Ehninger, Thomas Herrmann, et al.
World Journal of Urology|May 19, 2019
Outcomes of ureteroscopy for stone disease in anomalous kidneys: a systematic reviewLisa Lavan, Thomas Herrmann, Christopher Netsch, et al.
Pageof 23